Clin2
NCT06558656Likely a fitNot yet recruiting

How food affects a new drug in healthy volunteers

Complement-mediated Hemolytic Diseases

Treatments studied

Part of Blood & lymphatic clinical trials.

This study tests how a new oral drug (NTQ5082) is affected by food in healthy volunteers. You would take the drug once, and researchers will check how your body processes it with and without a meal.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
12 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be generally healthy, between 18 and 45 years old.
  • Your body mass index (BMI) must be between 19 and 26, and you must weigh at least 110 pounds (50 kg for men, 99 pounds (45 kg) for women).
  • You should not have any chronic illnesses or active medical problems, especially with your stomach, heart, immune system, or lungs.
  • You must not have taken any other experimental drugs or been in another clinical trial in the last 3 months.
  • You must be willing to avoid smoking, alcohol, caffeine, and certain foods (like grapefruit) during the study.
  • Women must not be pregnant or breastfeeding, and both men and women must use effective contraception during and for 3 months after the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06560593Not yet recruiting· Phase 1
Testing NTQ5082 in healthy volunteers

This trial tests a new drug called NTQ5082 in healthy people to see how safe it is and how the body processes it. If you qualify, you will help researchers understand the drug's effects before it is tested in patients with a disease.

Changsha, Hunan
NCT06980909Not yet recruiting· Phase 1
How food affects a new medicine in healthy volunteers

This study tests how food changes the way a new medicine (QLC1101) is absorbed and processed in the body. Healthy volunteers are needed to help understand the best way to take this medicine.

NCT07358858Not yet recruiting· Phase 1
How food affects a new study drug in healthy adults

This trial tests how a meal changes the way your body processes a new medication called QLS1410. It helps researchers understand if the drug should be taken with or without food.

NCT07565792Recruiting· Phase 1
How Food Affects a New Drug in Healthy Men

This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.

Hefei, Anhui
NCT07240636Recruiting· Phase 1
How food affects a new medicine in healthy volunteers

This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.

Hefei, Anhui
NCT07334262Not yet recruiting· Phase 1
Study of RNK08954 in healthy adults

This trial tests how a new drug called RNK08954 is processed by the body after food, and how it is eliminated. It is for healthy adults who want to help researchers understand the drug's safety and effects.

Shanghai

Hear when a new Complement-mediated Hemolytic Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.